更新关于与药物不良反应相关的HLA-B*15:02等位基因
Xueting Zhu1, Guanghua Luo1, Lu Zheng1
1Clinical Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Pharmacogenomics
|February 2, 2024
概括
人类白细胞抗原 (HLA) B*15:02等位基因与药物不良反应 (ADR) 有关. 本综述详细介绍了它与药物安全使用的关联,机制和临床管理策略.
科学领域:
- 免疫遗传学 免疫遗传学
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
背景情况:
- 人类白细胞抗原 (HLA) 等位基因,特别是在主要组织相容性复合体内,被认为是药物不良反应 (ADR) 的重要贡献者.
- HLA-B*15:02等位基因已成为关键的遗传因子,与严重的皮肤药物不良反应有关.
- 了解这些关联对于个性化医疗和药物安全至关重要.
研究的目的:
- 综合审查HLA-B*15:02等位基因与不同族群和各种药物中的ADR之间的关联.
- 阐明潜在的分子机制背后的HLA-B*15:02介导的ADRs,包括哈普识别.
- 通过分析HLA-B*15:02频率,基因型,成本效益和治疗策略,为临床决策提供基础.
主要方法:
- 文献综述综合了关于HLA-B*15:02与ADR相关的数据.
- 对药物基因组数据和免疫机制的探索.
- 流行病学数据的分析,基因定型技术和临床管理指南.
主要成果:
- 在各种人群中,已经观察到HLA-B*15:02和特定的ADR,如史蒂文斯-约翰逊综合征和有毒表皮解之间的强烈关联.
- 潜在的机制包括由药物-HLA相互作用引发的免疫反应.
- 对HLA-B*15:02的基因定型对于预防性药物安全措施变得越来越重要.
结论:
- HLA-B*15:02 基因型鉴定是预测和预防严重副作用的宝贵工具,特别是在卡巴马西平等药物中.
- 对精确机制的进一步研究可以导致新的治疗干预措施和药物开发策略.
- 实施药物遗传检测可以显著提高患者的安全性,并优化临床治疗计划.
更多相关视频
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
12.1K
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
14.8K
相关概念视频
01:27Allergic Drug Reactions
843
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
843
01:11Genetic Lingo
102.8K
Overview
102.8K
01:19Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
107
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
107
02:20Blood Types
17.6K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
17.6K
02:41Lethal Alleles
15.4K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.4K